Human Umbilical Cord Blood-Derived Serum forCulturing Human Mesenchymal S tromal Cells
- سال انتشار: 1401
- محل انتشار: بیست و سومین کنگره بین المللی هیبریدی پزشکی تولید مثل و هجدهمین کنگره هیبریدی فناوری سلولهای بنیادی رویان
- کد COI اختصاصی: RROYAN23_230
- زبان مقاله: انگلیسی
- تعداد مشاهده: 155
نویسندگان
Department of Research and Development, Royan S tem CellTechnology Company, Cord Blood Bank, Tehran, Iran
Department of S tem Cells and Developmental Biology, Cell ScienceResearch Center, Royan Ins titute for S tem Cell Biology andTechnology, ACECR, Tehran, Iran
Department of Research and Development, Royan S tem CellTechnology Company, Cord Blood Bank, Tehran, Iran
Department of S tem Cells and Developmental Biology, Cell ScienceResearch Center, Royan Ins titute for S tem Cell Biology andTechnology, ACECR, Tehran, Iran
Department of Research and Development, Royan S tem CellTechnology Company, Cord Blood Bank, Tehran, Iran.Department of Regenerative Medicine, Cell Science ResearchCenter, Royan Ins titute for S tem Cell Biology and Technology,ACECR, Tehran, Iran
چکیده
Objective: In the use of bovine fetal serum (FBS) there is concernabout the possibility of disease transmission from animalto human. Therefore, it seems necessary to create culture conditionsfree of animal serum, especially in cell therapy. This s tudyaimed to evaluate the feasibility of replacing human umbilicalcord serum (hUCS) with FBS for in vitro expansion of umbilicalcord mesenchymal s tromal/s tem cells (UC-MSCs).Materials and Methods: Here, UC-MSCs were cultured forfive days in media supplemented either by hUCS or commercialFBS (Gibco & HyClone) to compare their viability, proliferation,morphology, Immunophenotype, and differentiationpotential.Results: Notably, the rate of cell proliferation in the group containing۲% hUCS was the same. Our data shows that the useof ۵% and/or ۱۰% hUCS, resulted in a ۱۰-fold increase in thenumber of MSCs; While in the presence of commercial FBS,this figure reached a maximum of five times. as the groups containing۱۰% commercial FBS. Furthermore, there was no significantdifference between groups in terms of viability, surfacemarkers, and multilineage differentiation potential.Conclusion: These results demons trated that hUCS can efficientlyreplace FBS for the routine culture of MSCs and can beused ideally in the manufacturing process of UC-MSCs in thecell therapy indus tryکلیدواژه ها
Fetal Bovine Serum, Human Umbilical Cord BloodSerum, Mesenchymal S tem/S tromal Cells, Serum Supplementاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.